Welltower Inc. (WELL)
Real Estate · Health Care REITs · US stock · S&P 500 component
$234.85
▲ +0.22 (0.09%)
Day's range
$233.73 – $237.23
52-week range
$168.77 – $254.24
Red flags⚠ Heavy dilution
About Welltower Inc.
Welltower is a real estate investment trust that owns health care and senior living properties, including senior housing communities, outpatient medical buildings and some long-term care facilities. It earns income from rents and from operating partnerships in which residents pay for housing and care. The company invests in properties across North America and the United Kingdom, and its results are linked to demographic trends and occupancy at its communities.
Trailing twelve-month revenue stands at $9.4 billion, while revenue grew by 26.5% a year over the past three years. The company pays a dividend, and the yield is 1.3%. On the X-Ray Score, it is rated 53 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
Price chart
52-wk range $168.77 – $254.24Volume 1,805,600Daily, split-adjusted
Vitals
Market cap$170.6B
52-week range$168.77 – $254.24
Volume (last day)1,805,600
P/E (TTM)113.1
EBIT / EV yield–
Free-cash-flow yield–
Dividend yield1.3%
Revenue (TTM)$11.8B
Net income (TTM)$1.4B
Operating margin–
Return on capital–
Debt incl. leases$19.5B
Cash & securities$4.7B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
Not rated
REIT valuation (FFO multiples + DDM) not built yet: not rated
What this means
Read the lenses below
A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Real Estate peers. Open a lens to see the numbers behind it.
Valuation
Weak
10/100
Expensive against its sector on earnings and cash flow.
See the numbers →
Growth
Strong
91/100
Growing faster than most of its sector.
See the numbers →
Revenue growth (3y)22.7%
EPS growth (3y)66.7%
Growth consistency100%
Profitability
Weak
35/100
Earns lower returns on its capital than most peers.
See the numbers →
Gross profitability7.0%
Financial health
Fair
69/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score7 / 9
Dividends
Weak
41/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield1.3%
Dividend growth18.4%
Quarterly results: last 6 quarters
+28.6%
Dec '24
+30.3%
Mar '25
+39.6%
Jun '25
+30.6%
Sep '25
+41.3%
Dec '25
+38.3%
Mar '26
Revenue against the same quarter a year earlier. Latest quarter revenue $3.4B, diluted EPS $1.02.
Compare with peers
VTR Ventas, Inc.47 DOC Healthpeak Properties,...37Other Health Care REITs companies by X-Ray Score.
Fundamentals checklist
● 4 Good · ● 0 Average · ● 2 BadCash quality
Earnings backed by cashBad
Risk models
Piotroski F-ScoreGood
Growth
EPS growth (3y)Good
Revenue growth (3y)Good
Growth consistencyGood
Balance sheet
Valuation
Profitability
Gross profitabilityBad
Each check is graded against the company's sector, not a fixed number. Checklist score 45/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $4.7B | $5.9B | $6.6B | $8.0B | $10.8B |
| Operating income | $661M | $703M | $958M | $524M | – |
| Net income | $336M | $141M | $340M | $952M | $937M |
| Operating cash flow | $1.3B | $1.3B | $1.6B | $2.3B | $2.9B |
| Operating margin | 13.9% | 12.0% | 14.4% | 6.6% | – |
| Free cash flow | – | – | – | – | – |
| Diluted EPS | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 |
Fiscal years, from SEC filings.
Technical summary
Daily
Bullish
11 bullish · 1 neutral · 4 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
| SMA 10 | 228.2 | Bullish |
| EMA 10 | 230.5 | Bullish |
| SMA 20 | 229.5 | Bullish |
| EMA 20 | 230.4 | Bullish |
| SMA 50 | 233.4 | Bullish |
| EMA 50 | 231.3 | Bullish |
| SMA 100 | 228.9 | Bullish |
| EMA 100 | 227.5 | Bullish |
| SMA 200 | 215.1 | Bullish |
| EMA 200 | 215.5 | Bullish |
Oscillators (daily)
| RSI (14) | 57.15 | Neutral |
| MACD (12, 26) | -0.50 | Bearish |
| Momentum (12) | 2.00 | Bullish |
| Stochastic %K (14) | 81.59 | Bearish |
| Williams %R (14) | -18.41 | Bearish |
| CCI (20) | 113.2 | Bearish |
Pivot points (classic, last session)
S3 229.8 | S2 231.8 | S1 233.3 | Pivot 235.3 | R1 236.8 | R2 238.8 | R3 240.3 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
3.07 USD
Yield on today's price
1.31%
Frequency
Quarterly
Next ex-dividend date
Not announced
| Ex-dividend date | Amount per share |
|---|---|
| 12 Aug 2026 | 0.8500 |
| 13 May 2026 | 0.7400 |
| 25 Feb 2026 | 0.7400 |
| 10 Nov 2025 | 0.7400 |
| 12 Aug 2025 | 0.7400 |
| 14 May 2025 | 0.6700 |
| 25 Feb 2025 | 0.6700 |
| 13 Nov 2024 | 0.6700 |
| 12 Aug 2024 | 0.6700 |
| 10 May 2024 | 0.6100 |
| 22 Feb 2024 | 0.6100 |
| 13 Nov 2023 | 0.6100 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
WELL SEC filings
28 Jul 2026
8-KSEC EDGAR
Other events
28 Jul 2026
424B5SEC EDGAR
424B5
28 Jul 2026
10-QSEC EDGAR
Quarterly report
27 Jul 2026
8-KSEC EDGAR
Results of operations
13 Jul 2026
8-KSEC EDGAR
Other events
8 Jul 2026
424B5SEC EDGAR
424B5
6 Jul 2026
424B5SEC EDGAR
424B5
1 Jun 2026
8-KSEC EDGAR
Regulation FD disclosure
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.